Aristotle University Of Thessaloniki (AUTH)
Η επίδραση του λαζαροειδούς U-74389G και της σιλδεναφίλης στην πνευμονική λειτουργία κατά την ισχαιμία-επαναιμάτωση της καρδιάς: πειραματική μελέτη σε χοίρους
Abstract
dc:descriptionAcute tissue or organ ischemia is accompanied by a number of metabolic, energy, biochemical, inflammatory and electrolytic disorders, which determine the clinical outcome. The degree of tissue and cell damage and the severity of the clinical picture depend on the type of tissue that is undergoing acute ischemia as well as by its degree (complete or partial) and its duration. Reperfusion is an essential factor in preventing irreversible cellular and tissue damage can increase the intensity and extent of cellular and tissue damage, leading to cell death. All of these disorders are termed ischemia-reperfusion syndrome. The main mechanisms that appear to be involved in the ischemia-reperfusion injury are complex and multifactorial with major: •the production of free oxygen radicals •an increase in calcium concentrations, •disruption of cell membrane structure •endothelial dysfunction, and •the severe inflammatory reaction.The side effects of ischemia-reperfusion syndrome are not only limited to the specific tissue that is undergoing primary ischemia. Often depending on the timing and degree of ischemia, reperfusion can cause severe damage to remote organs. The lungs are particularly vulnerable, particularly after ischemia - reperfusion of the bowel and / or liver and one of the first clinical symptoms preceding manifestations of other organ failure is respiratory dysfunction. Histopathological lesions are characterized by haemorrhagic filling of the cells and fibrosis of the interalveolar and interlobular diaphragms, hyperemia of small pulmonary vessels, finding of fibrous red cells and macrophages with hemosiderin granules in the lumen of the 2nd class bronchus, endothelial cell hyperplasia and narrowing of the alveolar capillary lumen, increased number of type II lung cells and thickening of the basic membrane of the alveolar epithelium. The mechanisms that lead to the failure of many organs are the same as those involved in local organ dysfunction as a result of ischemia / reperfusion.Although several treatment strategies have been found to be effective at an experimental level, the same efficiency could not be achieved at a clinical level. As a result, the timely reperfusion of the ischemic area continues to remain the cornerstone of a successful clinical treatment. As the knowledge upon the pathophysiology of this syndrome is developing, many researchers have tried to test the efficacy of pharmaceutical substances and factors that hinder or promote certain procedures.Sildenafil has been found to protect the heart from ischemia-reperfusion damage, to reduce cardiac hypertrophy and to improve heart function in cases of chronic hypertension. The Lazaroid U-74389G suspends the peroxidation of the lipids in the cell membrane, decreases the release of arachidonic acid from the cell membranes and increases the stability of the cellular membrane. This experimental study has been designed with the intention to evaluate the results which derive from the administration of the pharmaceutical substance U-74389G (Lazaroid) and Sildenafil, separately or combined, during anaesthesia in a procedure of ischemia-reperfusion of the myocardium, in reference to pulmonary function. Method: 56 animal prototypes were used which were separated randomly in the following seven (7) experimental groups of eight (8) animal prototypes each. Group A (Category 1), to which anaesthesia with sevoflurane was administered, was the control group. Groups C, E and Z constituted Category 2 with intravenous administration of controlled pharmaceutical substances 10 min. before the initiation of acute ischemia.Groups B, D, ST constituted Category 3 with intravenous administration of controlled pharmaceutical substances directly before reperfusion. The Lazaroid U-74389G was administered to Groups B and C, Sildenafil to Groups D and E and both the Lazaroid U-74389G and Sildenafil were administered to groups ST and Z. The time needed for the myocardial ischemia was 30min. and for the reperfusion 120min. The Hemodynamic control parameters were: a. Systolic, Diastolic and Mean Arterial Pressure, b. Heart rate and, c. Arterial Blood Gases (pH, pO2, pCO2, HCO3, SaTO2, Base Deficit). The Blood Control Indicators were the number of white blood cells and the ratio of polymorphonuclear cells and lymphocytes, the number of platelets, Fibrinogen, D-Dimers and INR. The Biochemical Control Indicators were Glucose, Oxaloacetic Transferase (SGOT), Pyruvic Transferase (SGPT), Creatine Phosphokinase (CPK) and CRP.From all the Inflammatory Reaction Mediators, the following were checked,endothelin -1 and -2 in the serum, interleukin -6 and -10 (IL-6), (IL-10) and MPO (malondialdehyde). ATP, ADP and AMP were defined to check the energy load and the tissue lesions in lung samples were checked with the optical microscope. Blood and tissue samples were collected at a specific time, directly before inducing ischemia, 15 min. and 30 min. after inducing ischemia, at the beginning of reperfusion, 30 min., 60 min. and 120 min. after the beginning of reperfusion. Results: At a clinical level, administering the Lazaroid U-74389G or Sildenafil before the onset of ischemia appears to have better results. Also, administering either of the pharmaceutical substances seems to have no advantage over the other. The possible action mechanism as far as Sildenafil is concerned is its protective action on the myocardium, while as far as the Lazaroid U-74389G is concerned, its anti-inflammatory and stabilizing action on the membranes in the lungs. Co-administering the Lazaroid U-74389G and Sildenafil does not offer better results.From the parameters which provide immediate results A. The Hemodynamic control parameters (systolic, diastolic and mean Arterial Pressure, blood gases), B. The number of white blood cells, polymorphonuclear cells and lymphocytes and, C. The biochemical indicators, (glucose, SGOT, SGPT, CPK, CRP),do not offer reliable data to evaluate the action of controlled pharmaceutical substances. However, wherever there are statistically important differences they concern intravenous administration of controlled pharmaceutical substances mainly before the initiation of ischemia. D. The control indicators of the thickening mechanism, (Fibrinogen, INR, D-Dimers) offer data which highlight differences, which should be read carefully. E. From the parameters which check the size of the inflammatory reaction and the action of free oxygen radicals (endothelins -1 and -2, interleukins -6 and -10, MPO, TNF-α and Malondialdehyde-MDA) only the changes of TNF-α are considered to be representative of the damage, despite the fact that other experimental studies, on a different kind of tissues, provide results with credible and representative of the damage values of the other indicators as well. One possible explanation for this difference might be the small amount of time of the myocardial ischemia and the attempt to associate any changes of these parameters with damages to a remote organ. ST. Moreover, evidence did not emerge from the control parameters of the intracellular metabolism of the lungs (ATP, ADP, AMP and Energy Load), which could be considered as representative of the damage. Z. Finally, the results from the histological examination via the optical microscope did not highlight any particular variations among the groups. One possible explanation to this phenomenon is rapid reperfusion. Conclusions: The intravenous administration of the Lazaroid U-74389G or Sildenafil before inducing acute ischemia to the myocardium of the swines appears to offer some advantages concerning the reduction of damage to remote organs and in the case of the lung, the advantages concern the ischemia-reperfusion syndrome. Co-administration of both substances seems to bring no benefits. The intravenous administration of the Lazaroid U-74389G or Sildenafil before inducing reperfusion offers less benefits in cases of acute ischemia-reperfusion of the myocardium as far as the reduction of damage to remote organs and the lung are concerned,. Therefore, more studies and, more specifically, more clinical studies are required in order to fully corroborate their action.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kamparoudi, Pagona
- Καμπαρούδη, Παγώνα
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46973